冠心病患者血清载脂蛋白与纤溶功能的变化及其相关性研究

Changes and correlation of fibrinolytic function and apolipoprotein in patients with coronary heart disease

下载PDF

导出

作者刘志军黄建宁张珺赵淑清

出处《第三军医大学学报》 CAS CSCD 北大核心 2005年第19期1999-2000,共2页 Journal of Third Military Medical University

关键词冠心病血清载脂蛋白纤溶系统

参考文献7

1Jovin I S, Muller Berghaus G. Interrelationships between the fibrinolytic system and lipoproteins in the pathogenesis of coronary atherosclerosis[J]. Atherosclerosis, 2004, 174(2): 225-233.
2Rahmani M, Raiszadeh F, Allahverdian S, et al. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxonase enzyme activity in Iranian subjects[J]. Atherosclerosis, 2002, 162(2): 381 -389.
3Havel R J, Rapaport E. Management of primary hyperlipidemia[J]. N Engl J Med, 1995, 332(22): 1491 -1498.
4谢瑞芹,王凤飞,都本洁,都军,张玉华,李荣华.凝血纤溶指标的变化与缺血性心脏病的关系[J].中国介入心脏病学杂志,1997,5(1):23-25. 被引量：12
5Seljeflot I, Tonstad S, Hjermann I, et al. Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease[J]. Thromb Res, 2002, 105(4): 285 -290.
6明亮.冠心病患者血脂测定[J].郑州大学学报（医学版）,2004,39(6):1104-1105. 被引量：2
7Blum A, Lang N, Vigder F, et al. Effects of soy protein on endothelium-dependent vasodilatation and lipid profile in postmenopausal women with mild hypercholesterolemia[J]. Clin Invest Med, 2003, 26 (1):20 - 26.

1宋善俊,李学军,魏文宁,刘莉,胡俊斌.尿液中纤维蛋白肽A的高效液相色谱检测[J].中华血液学杂志,1996,17(2):103-104. 被引量：17
2Velho G, Erlich D, Turpin E,et al. Lipoprotein(a) in diabetic patients and normoglycemic relatives in familial NIDDM. Diabetes Care, 1993,16(5):742
3Joven J, Viella E. Serum levels of lipoprotein(a)in patients with well controlled non-insulin-dependent diabetes mellitus. JAMA,1991, 265(9):1 113
4Haffner S,Moss S, Klein B,et al.Lack of association between Lp(a)concentrations and coronary heart disease mortality in diabetes:the Wisconsin Epidemiologic Study of Diabetic Retinopathy.Metabolism,1992, 41(2):194
5Cressman MD,Heyka KJ,Paganini EP,et al. Lipoprotein(a) is an independent risk factor cardiovascular disease in hemodialysis patients.Circulation,1992, 86(12):475
6Oparil S, Oberman A.Nontraditional cardiovascular risk factors. Am J Med Sci,1999,317(3):193
7李健斋.血脂分析在心血管疾病临床应用中的若干问题[J].临床检验杂志,1997,15(5):310-312. 被引量：28

1王东琦,王归真,李云萍,娄莉,高晖,崔长琮.单项血脂和血脂比值与冠状动脉病变严重程度的相关性[J].西安交通大学学报（医学版）,2007,28(3):259-262. 被引量：6
2赵勇,牛翠,刘燕.血浆D-二聚体浓度与冠脉病变程度的相关性[J].心血管康复医学杂志,2010,19(3):260-262. 被引量：6
3王燕妮,彭燕蓁,祝家庆,王晓琴.纤溶指标在急性冠状动脉事件中的变化及临床意义[J].中国循环杂志,1999,14(3):135-136. 被引量：7
4吴乾虎.D-二聚体的检测及其与心血管疾病的关系[J].标记免疫分析与临床,2000,7(1):32-35. 被引量：2
5韦汐.血液检测指标对急性心肌梗死溶栓成功的诊断价值[J].蛇志,2000,12(1):78-80.
6黄艳琴,谢朝阳,孙俊影.降纤酶治疗不稳定心绞痛的疗效观察[J].河南医药信息,2001,9(2):53-53.
7张波,李小鹰,李学军.老年不稳定型心绞痛患者血浆D-二聚体检测的临床意义[J].解放军医学杂志,2001,26(4):254-255. 被引量：1
8孟晓梅,孟军,董国雄.D-二聚体与急性冠状动脉事件[J].山东医药,2001,41(10):57-58. 被引量：1
9李红莉,赵洪清,张一娜,付锦.原发性高血压患者的纤维蛋白溶解活性变化[J].哈尔滨医科大学学报,2001,35(6):442-443.
10尹士全,刘霜,孙根义,阚跃东,谢鸿旗.纤溶酶原激活剂抑制物-1及其基因多态性与急性心肌梗死的相关性研究[J].天津医药,2003,31(3):131-133. 被引量：1

第三军医大学学报

2005年第19期

内容加载中请稍等...